Heska Corp. (NASDAQ:HSKA) is scheduled to release its earnings data before the market opens on Wednesday, July 27th.
Heska Corp. (NASDAQ:HSKA) last issued its quarterly earnings results on Tuesday, May 3rd. The company reported $0.17 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.02) by $0.19. The business had revenue of $27.10 million for the quarter, compared to analyst estimates of $23.32 million. On average, analysts expect Heska Corp. to post $0.85 EPS for the current fiscal year and $1.27 EPS for the next fiscal year.
Several research firms have recently issued reports on HSKA. B. Riley reissued a “buy” rating and issued a $42.50 price target on shares of Heska Corp. in a research note on Wednesday, May 4th. Zacks Investment Research raised Heska Corp. from a “hold” rating to a “buy” rating and set a $48.00 price target for the company in a research note on Wednesday, July 13th. Sidoti began coverage on Heska Corp. in a research note on Friday, July 1st. They issued a “buy” rating and a $49.00 price target for the company. TheStreet raised Heska Corp. from a “hold” rating to a “buy” rating in a research note on Wednesday, May 25th. Finally, CL King began coverage on Heska Corp. in a research note on Friday, April 1st. They issued a “buy” rating for the company. Five investment analysts have rated the stock with a buy rating, The company currently has an average rating of “Buy” and a consensus price target of $46.50.
In related news, CEO Kevin S. Wilson sold 11,000 shares of the firm’s stock in a transaction dated Monday, May 9th. The stock was sold at an average price of $35.61, for a total transaction of $391,710.00. Following the completion of the transaction, the chief executive officer now owns 228,718 shares of the company’s stock, valued at $8,144,647.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Kevin S. Wilson sold 15,000 shares of the firm’s stock in a transaction dated Tuesday, May 10th. The shares were sold at an average price of $36.75, for a total value of $551,250.00. Following the transaction, the chief executive officer now directly owns 210,000 shares of the company’s stock, valued at approximately $7,717,500. The disclosure for this sale can be found here.
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals.
